Jiaogulan for Cholesterol Management

Research suggests that jiaogulan (Gynostemma pentaphyllum) and its active compounds, gypenosides, may help reduce total cholesterol, LDL cholesterol, and triglycerides, based on a small body of preclinical studies conducted in rats and human cell models. Studies indicate that these effects may involve multiple mechanisms, including modulation of lipid metabolism pathways, reduction of liver inflammation, and favorable shifts in gut microbiome composition — such as increased populations of beneficial bacteria like Lactobacillus and Akkermansia. All available studies in this collection are animal or cell-based research, meaning findings cannot be directly applied to humans, and no randomized controlled trials or human clinical studies are represented here. While the overall direction of this research is supportive, the absence of human trial data represents a significant limitation, and readers should interpret these findings as preliminary evidence warranting further investigation rather than established clinical guidance.